To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents

NCT00811980 ·Status: COMPLETED

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections

NCT00427076 ·Status: COMPLETED ·Phase: PHASE3

Personalized Optimization of Antibiotic Therapy in Pulmonary Sepsis Critically Ill Patients Through Application of Rapid Microbiological Diagnostic Technologies and Pharmacokinetic/Pharmacodynamic Modelling

NCT06956053 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis

NCT02685033 ·Status: COMPLETED ·Phase: PHASE2

FOUR-SIX TRIAL for the Treatment of Enterococcal Endocarditis

NCT05398289 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT06069206 ·Status: COMPLETED ·Phase: NA

Impact of Prophylactic Antibiotics on Bloodstream Infections After Liberation From Extracorporeal Membrane Oxygenation

NCT05651464 ·Status: UNKNOWN ·Phase: NA

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

NCT01370616 ·Status: COMPLETED ·Phase: PHASE3

Prospective Randomized Trial of Bactrim on 7 Day Outcome in Patients With Uncomplicated Abscesses

NCT00973765 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

NCT01626560 ·Status: COMPLETED ·Phase: PHASE4

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

NCT00695903 ·Status: TERMINATED ·Phase: PHASE2

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

NCT04983901 ·Status: COMPLETED ·Phase: PHASE2

Ambulatory Administration of Meropenem With Elastomeric Pumps and an Isothermal Pouch

NCT04809259 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC

NCT04793152 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis

NCT03148756 ·Status: TERMINATED ·Phase: PHASE2

The Immunostimulatory Effects of Gentamicin

NCT05303909 ·Status: TERMINATED ·Phase: PHASE2

Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia

NCT01975662 ·Status: TERMINATED ·Phase: PHASE2

Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections

NCT05942157 ·Status: RECRUITING ·Phase: NA

Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

NCT03630081 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

The Role of the Microbiota in the Systemic Immune Response

NCT02340182 ·Status: COMPLETED ·Phase: NA

Population Pharmacokinetics of Anti-infectives in Hospitalized Patients

NCT02998411 ·Status: RECRUITING

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

NCT01252732 ·Status: COMPLETED ·Phase: PHASE3

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

NCT05210387 ·Status: TERMINATED ·Phase: NA

Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

NCT05210439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

NCT00138112 ·Status: COMPLETED ·Phase: PHASE3